BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 21, 2019
View Archived Issues
Chaperone keeps prion protein on best behavior in mice and macaques
Read More
CHMFL-FLT3-335 demonstrates antitumor efficacy in vivo
Read More
Sosei initiates new clinical program with HTL-0030310 for endocrine disorders
Read More
RGFP-966, an HDAC3 inhibitor, suppresses drug-seeking behavior in rats
Read More
AJ-20064 demonstrates promising antitumor activity in lung cancer models
Read More
Positive data presented from phase II PHOENIX study of bardoxolone methyl
Read More
First patient enrolled in phase III study of troriluzole in generalized anxiety disorder
Read More
Sanofi patents new antimycobacterial compounds
Read More
Esteve Pharmaceuticals discloses new analgesics
Read More
Takeda Pharmaceutical identifies new GluN2B receptor antagonists
Read More
Torque begins first-in-human study of TRQ-1501 and plans evaluation with Keytruda
Read More
GlaxoSmithKline patents PERK inhibitors
Read More
January Therapeutics synthesizes gemcitabine prodrugs
Read More
Antitumor agent Temodal obtains additional indication approval for Ewing's sarcoma in Japan
Read More
Pluristem, NASA enter collaboration to study PLX cell therapies in space missions
Read More
New phase I study explores use of cardiac troponin activator AMG-594 in healthy subjects
Read More
FDA clears IND for phase I study of KT-1002 for IBD
Read More
Study evaluates nitisinone for 1 year in patients with oculocutaneous albinism
Read More
Mustang and National Children's Hospital partner to develop C-134 for GBM
Read More
Faron reports early observations on first patients in MATINS study of Clevegen
Read More
KEYNOTE-240 trial of Keytruda in previously treated HCC does not meet primary endpoint
Read More
Alkermes, Clovis Oncology enter collaboration to explore combination cancer therapies
Read More
DDR1 inhibitor seen to prevent renal function loss in mice
Read More
Mallinckrodt reports interim phase III results with Uvadex and Therakos platform in pediatric GvHD
Read More